These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 2542691)

  • 1. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers.
    Van Aswegen CH; Purdy RH; Wittliff JL
    J Steroid Biochem; 1989 Apr; 32(4):485-92. PubMed ID: 2542691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to the estrogen receptor of MCF-7 cells in cytosolic extracts and in nuclei of intact cells.
    Schütze N; Vollmer G; Wünsche W; Grote A; Feit B; Knuppen R
    Exp Clin Endocrinol; 1994; 102(5):399-408. PubMed ID: 7867704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholestrogens are MCF-7 cell estrogen receptor agonists.
    Schütze N; Vollmer G; Tiemann I; Geiger M; Knuppen R
    J Steroid Biochem Mol Biol; 1993 Dec; 46(6):781-9. PubMed ID: 8274412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of 4-(hydroxyalkyl)estradiols and related compounds.
    Lovely CJ; Bhat AS; Coughenour HD; Gilbert NE; Brueggemeier RW
    J Med Chem; 1997 Nov; 40(23):3756-64. PubMed ID: 9371241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative properties of the catechol estrogens, I: methylation by catechol-O-methyltransferase and binding to cytosol estrogen receptors.
    Merriam GR; MacLusky NJ; Picard MK; Naftolin F
    Steroids; 1980 Jul; 36(1):1-11. PubMed ID: 7426122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-hydroxyestradiol-17 alpha and 4-hydroxyestradiol-17 alpha, catechol estrogen analogs with reduced estrogen receptor affinity.
    Merriam GR; MacLusky NJ; Johnson LA; Naftolin F
    Steroids; 1980 Jul; 36(1):13-20. PubMed ID: 7414655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of catecholestrogens with cytoplasmic and nuclear estrogen receptors in rat pituitary gland and hypothalamus.
    Kirchhoff J; Hornung E; Ghraf R; Ball P; Knuppen R
    J Neurochem; 1981 Dec; 37(6):1540-7. PubMed ID: 6278079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The characteristic binding of catechol estrogens to estrogen receptors in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Tanaka T; Katoh M; Kubodera A
    Steroids; 1986; 48(5-6):361-8. PubMed ID: 2832979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol.
    Dawling S; Hachey DL; Roodi N; Parl FF
    Chem Res Toxicol; 2004 Sep; 17(9):1258-64. PubMed ID: 15377160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor-independent catechol estrogen binding activity: protein binding studies in wild-type, Estrogen receptor-alpha KO, and aromatase KO mice tissues.
    Philips BJ; Ansell PJ; Newton LG; Harada N; Honda S; Ganjam VK; Rottinghaus GE; Welshons WV; Lubahn DB
    Biochemistry; 2004 Jun; 43(21):6698-708. PubMed ID: 15157104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis.
    Ashburn SP; Han X; Liehr JG
    Mol Pharmacol; 1993 Apr; 43(4):534-41. PubMed ID: 8386306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The carcinogenic activity of ethinyl estrogens is determined by both their hormonal characteristics and their conversion to catechol metabolites.
    Zhu BT; Roy D; Liehr JG
    Endocrinology; 1993 Feb; 132(2):577-83. PubMed ID: 8381068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-(Hydroxyalkyl)estradiols: synthesis and biological evaluation.
    Lovely CJ; Gilbert NE; Liberto MM; Sharp DW; Lin YC; Brueggemeier RW
    J Med Chem; 1996 Apr; 39(9):1917-23. PubMed ID: 8627615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of the estrogen receptor in the human oviduct and its interaction with ethinylestradiol and mestranol in vitro.
    Muechler EK; Kohler D
    J Clin Endocrinol Metab; 1980 Nov; 51(5):962-7. PubMed ID: 7419693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Hydroxylation of estrogens as marker of human mammary tumors.
    Liehr JG; Ricci MJ
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3294-6. PubMed ID: 8622931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical hypothesis: hyperhomocysteinemia is a risk factor for estrogen-induced hormonal cancer.
    Zhu BT
    Int J Oncol; 2003 Mar; 22(3):499-508. PubMed ID: 12579301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The catechol estrogen, 2-hydroxyestradiol-17 alpha, is formed from estradiol-17 alpha by hypothalamic tissue in vitro and inhibits tyrosine hydroxylase.
    Hersey RM; Lloyd T; MacLusky NJ; Weisz J
    Endocrinology; 1982 Nov; 111(5):1734-6. PubMed ID: 6127206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist-antagonist activity of anti-estrogens in the human breast cancer cell line MCF-7: an hypothesis for the interaction with a site distinct from the estrogen binding site.
    Berthois Y; Pons M; Dussert C; Crastes de Paulet A; Martin PM
    Mol Cell Endocrinol; 1994 Mar; 99(2):259-68. PubMed ID: 8206333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of methylestrogens with cytoplasmic and nuclear estrogen receptors in rat pituitary gland, hypothalamus and uterus.
    Kirchhoff J; Wang X; Ghraf R; Ball P; Knuppen R
    Brain Res; 1984 Mar; 294(2):354-8. PubMed ID: 6322922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.